Literature DB >> 26391022

Statistical approaches for evaluating surrogate outcomes in clinical trials: A systematic review.

Hannah Ensor1, Robert J Lee1, Cathie Sudlow2, Christopher J Weir1,3.   

Abstract

The use of surrogate outcomes that predict treatment effect on an unobserved true outcome may have substantial economic and ethical advantages, through reducing the length and size of clinical trials. There has been extensive investigation of the best means of evaluating putative surrogates. We present a systematic review on the evolution of statistical methods for validating surrogates starting from the defining paper of Prentice (1989). We highlight the fundamental differences in the current statistical evaluation approaches, their advantages and disadvantages, and examine the understanding and perceptions of investigators in this area.

Entities:  

Keywords:  Clinical trials; statistical methodology; surrogate evaluation; systematic review

Mesh:

Substances:

Year:  2015        PMID: 26391022     DOI: 10.1080/10543406.2015.1094811

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  6 in total

1.  ALS/SURV: a modification of the CAFS statistic.

Authors:  Stephen A Goutman; Morton B Brown; Merit Cudkowicz; Nazem Atassi; Eva L Feldman
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-07-23       Impact factor: 4.092

2.  Optimizing the development and evaluation of complex interventions: lessons learned from the BetterBirth Program and associated trial.

Authors:  Dale A Barnhart; Katherine E A Semrau; Corwin M Zigler; Rose L Molina; Megan Marx Delaney; Lisa R Hirschhorn; Donna Spiegelman
Journal:  Implement Sci Commun       Date:  2020-02-25

3.  Links between causal effects and causal association for surrogacy evaluation in a gaussian setting.

Authors:  Anna Conlon; Jeremy Taylor; Yun Li; Karla Diaz-Ordaz; Michael Elliott
Journal:  Stat Med       Date:  2017-08-08       Impact factor: 2.373

Review 4.  A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?

Authors:  Ana Rath; Valérie Salamon; Sandra Peixoto; Virginie Hivert; Martine Laville; Berenice Segrestin; Edmund A M Neugebauer; Michaela Eikermann; Vittorio Bertele; Silvio Garattini; Jørn Wetterslev; Rita Banzi; Janus C Jakobsen; Snezana Djurisic; Christine Kubiak; Jacques Demotes-Mainard; Christian Gluud
Journal:  Trials       Date:  2017-11-22       Impact factor: 2.279

Review 5.  Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.

Authors:  Christopher J Weir; Rod S Taylor
Journal:  Pharm Stat       Date:  2022-07       Impact factor: 1.234

6.  Evaluation of surrogacy in the multi-trial setting based on information theory: an extension to ordinal outcomes.

Authors:  Hannah Ensor; Christopher J Weir
Journal:  J Biopharm Stat       Date:  2019-12-30       Impact factor: 1.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.